GlassScriptPhysician profile
Anthony C Canino
NPI 1396714036
$1,304.93
in general payments reported to CMS, 2019-2025
21 companies · $217 in 2025
The $217 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $179 · 2020: $163 · 2021: $50.39 · 2022: $317 · 2023: $172 · 2024: $207 · 2025: $217.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $596.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $595.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $230.13 | 2019-2022 | |
| Exeltis, USA INC. | $179.54 | 2020-2025 | Slynd |
| Karl Storz Endoscopy-America | $117.79 | 2023 | |
| Pfizer INC. | $103.81 | 2019-2023 | |
| Davol INC. | $75.26 | 2019-2024 | Arista Ah Flexitip |
| Ethicon US, LLC | $73.91 | 2022 | |
| Merck Sharp & Dohme LLC | $70.48 | 2019-2021 | |
| Organon LLC | $64.80 | 2022-2023 | Nexplanon |
| Baxter Healthcare | $61.08 | 2024-2025 | Perclot |
| Astellas Pharma US INC | $47.42 | 2023-2024 | Veozah |
| Sumitomo Pharma America, INC. | $44.70 | 2025 | Myfembree |
| Coopersurgical, INC. | $35.88 | 2022-2024 | Supercut Hysterectomy Scissors |
| Biogen, INC. | $28.35 | 2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $26.18 | 2019-2020 | |
| Amgen INC. | $25.33 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $24.91 | 2020 | |
| Lupin INC. | $23.74 | 2019 | |
| 180 Medical, INC. | $21.94 | 2024 | Gentlecath |
| Meditrina | $21.93 | 2025 | |
| Mayne Pharma Commercial LLC | $15.04 | 2025 | |
| Coloplast Corp | $12.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Canino listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.